This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barbas, C.F. et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230, 812–823 (1993).
Ditzel, H.J. et al. Mapping the protein surface of HIV-1 gp120 using human monoclonal antibodies from phage display libraries. J. Mol. Biol. 267, 684–695 (1997).
Earl, P.L. et al. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68, 3015–3026 (1994).
Parren, P.W.H.I. et al. In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. J. Virol. 70, 9046–9050 (1996).
Roben, P. et al. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68, 4821–4828 (1994).
Sattentau, Q.J. & Moore, J.P. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185–196 (1995).
D'Souza, M.P. et al. Evaluation of monoclonal antibodies to HIV-1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. J. Infect. Dis. 175, 1056–1062 (1997).
Willey, R.L. et al. Biosynthesis, cleavage and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85, 9580–9584 (1988).
Davenport, F.M. & Hennessy, A.V. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. Exp. Med. 106, 835–850 (1957).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parren, P., Burton, D. & Sattentau, Q. HIV-1 antibody — debris or virion?. Nat Med 3, 366–367 (1997). https://doi.org/10.1038/nm0497-366d
Issue Date:
DOI: https://doi.org/10.1038/nm0497-366d
This article is cited by
-
Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies
Scientific Reports (2020)
-
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
Retrovirology (2014)
-
Development of prophylactic vaccines against HIV-1
Retrovirology (2013)
-
Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of anti-V3 antibody content and antiretroviral theraphy
The Journal of Microbiology (2012)
-
A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells
Retrovirology (2011)